Market News & Trends
Cellevate Demonstrates Successful Scale-Up of its Cellevat3d Nanofiber Microcarriers for Biomanufacturing at Testa Center
Cellevate recently announced the successful scale-up of its ground-breaking Cellevat3d nanofiber microcarriers funded by Vinnova/STUNS Life Science. The study was performed at Testa Center in…
ViaNautis Bio Signs Strategic Collaboration Agreement With Lilly to Develop Novel Products Delivering Genetic Medicines
ViaNautis Bio recently announced a collaboration with Eli Lilly and Company in which ViaNautis will receive an initial upfront payment from Lilly, with the short-term…
Candel Therapeutics Showcases Innovative Cancer Therapy Candidates
Candel Therapeutics, Inc. recently announced three presentations at the 16th Annual International Oncolytic Virotherapy Conference (IOVC), taking place October 27-30, 2024, in Rotterdam, the Netherlands. The…
Biora Therapeutics Shares Progress on Smaller BioJet Clinical Device With Largest Payload of Any Ingestible Injectable
Biora Therapeutics, Inc. is sharing progress on its development of the BioJet Oral Delivery Platform, which is designed to replace injection with needle-free, oral delivery,…
Pluri Collaborates With Bar-Ilan University to Advance Cancer Immunotherapy for Solid Tumors
Pluri Inc. recently announced the Israel Innovation Authority (IIA) will fund Pluri’s collaboration with the Bar-Ilan University Research and Development Company Ltd., (BIRAD), the commercial…
Lisata Therapeutics Announces Sponsored Preclinical Research Agreement With University of Cincinnati to Study for Endometriosis Treatment
Lisata Therapeutics, Inc. recently announced it has entered into a sponsored research agreement with the University of Cincinnati to investigate Lisata’s novel cyclic peptide product…
First-Ever Long-Acting Injectable for Malaria Prevention Administered to Study Volunteers
Medicines for Malaria Venture (MMV) and Quotient Sciences have begun the first clinical trial for a long-acting injectable (LAI) preventive compound for malaria. The trial,…
Catalent Boston Adds to Oral Spray Drying Capacity & Capabilities to Support Late-Stage Clinical Trials & Commercialization
Catalent, the leading provider of oral drug development solutions, bioavailability enhancing technologies, and flexible manufacturing, has completed a series of upgrades to its large-scale spray…
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell & NK Cell Engagers Antibody Platform
Purple Biotech Ltd. recently announced new data regarding its tri-specific antibody platform, CAPTN-3, which were presented at the 36th European Organization for Research and Treatment…
Ocuphire Pharma Announces Acquisition of Opus Genetics
Ocuphire Pharma, Inc. recently announced the all-stock acquisition of Opus Genetics, Inc., a clinical-stage gene therapy company for inherited retinal diseases (IRDs). The merger creates…
Interius BioTherapeutics Doses First Patient With In Vivo Chimeric Antigen Receptor Gene Therapy for B-Cell Malignancies
Interius BioTherapeutics recently announced the first study participant has been dosed in INVISE, its first-in-human Phase 1 clinical trial of INT2104, a first-in-class gene therapy…
Nimbus Therapeutics Presents First Preclinical Data on Novel WRN Inhibitor
Nimbus Therapeutics, LLC recently announced it presented preclinical data on its new development candidate, NTX-452, a novel Werner syndrome helicase (WRN) inhibitor, at the 36th…
Aptar Awarded Federal Government Contract to Advance Novel Sterilization Technology for Medical Devices
AptarGroup, Inc. recently announced it was awarded a contract from the US Federal Government to advance development of its ActivShield technology. This innovative solution sterilizes…
Lonza Extends Collaboration With Major Pharmaceutical Partner for Integrated Commercial Supply of Antibody-Drug Conjugates
Lonza recently announced a long-term extension of its collaboration with a major global biopharmaceutical partner for commercial-scale manufacture of ADCs. The extended agreement will expand…
BD & Ypsomed Collaborate to Advance Self-Injection Systems for High-Viscosity Biologics
BD (Becton, Dickinson and Company) recently announced a strategic collaboration with Ypsomed to advance self-injection solutions for high-viscosity biologic drugs. In a joint project, Ypsomed and…
PolTREG Launches Phase 2 Cell Therapy Trial in Children With Presymptomatic Diabetes
PolTREG S.A. has launched a placebo-controlled Phase 2 clinical trial with PTG-007 Treg cell therapy in presymptomatic type-1 diabetes (T1D) patients, after receiving approval from…
Rentschler Biopharma Announces Largest Single Investment at its Headquarters in Germany
Rentschler Biopharma SE recently announced the construction of a new state-of-the-art buffer media station at its company headquarters in Laupheim. The new facility aims to…
Rhythm Pharmaceuticals & Axovia Therapeutics Announce Joint Research Collaboration in Bardet-Biedl Syndrome
Rhythm Pharmaceuticals, Inc. and Axovia Therapeutics Ltd. recently announced a joint research collaboration designed to advance the understanding of Bardet-Biedl syndrome (BBS). “We believe there…
UPM Biomedicals Launches FibGel, World’s First Injectable Nanocellulose Hydrogel for Medical Devices
UPM Biomedicals recently announced the launch of FibGel, a natural injectable hydrogel for permanent implantable medical devices. FibGel is a nanofibrillar cellulose hydrogel made from…
GRI Bio Raises $13.9 Million in Gross Proceeds Since the Beginning of 2024
GRI Bio, Inc. recently announced it closed its previously announced transaction involving the exercise of certain existing warrants to purchase an aggregate of 762,236 shares…
